Navigation Links
$8.9 million NIH grant to study genomic link to premature heart disease
Date:9/14/2012

WINSTON-SALEM, N.C., Sept. 10, 2012 Researchers at Wake Forest Baptist Medical Center are leading a four-year, $8.9 million national project to identify variations in the human genome and corresponding changes in the arterial proteins associated with premature development of atherosclerosis.

The other institutions collaborating with Wake Forest Baptist in this project are Harvard Medical School, The Johns Hopkins UniversityBayview Campus, Virginia Polytechnic Institute and State University, Blacksburg, Va., The University of Texas Science Center at Houston, and Louisiana State Health Sciences Center, New Orleans.

The purpose of this collaborative study is to provide novel insights into the interdependent networks of genes and proteins that put some individuals at risk of premature cardiovascular disease. Ultimately, such information could lead to new screening strategies and help identify new therapeutic targets to reduce the human and financial costs of cardiovascular disease worldwide.

Researchers will analyze data from a unique, NIH-funded repository held at Louisiana State Health Sciences Center that provides data, DNA and tissue samples from 3,400 young (15- to 34-year-old) multi-ethnic subjects who died of non-cardiovascular causes.

David M. Herrington, M.D., MHS, professor of Cardiology, and principal investigator for this national collaboration, says the aim is to create a detailed molecular characterization of arterial tissue with the purpose of identifying the genetic variants associated with premature cardiovascular disease. "By using state-of-the-art molecular and analytic methods, we will be able to determine the genomic and proteomic architecture of premature atherosclerosis," Herrington said. "This will add fundamentally new knowledge about the link between the genome and the proteome in the artery wall."


'/>"/>

Contact: Paula Faria
pfaria@wakehealth.edu
336-716-1279
Wake Forest Baptist Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. UCF nanoscientist receives $2 million NIH award
2. Saving brains in developing countries: $11.8 million for innovative ideas worldwide
3. Funding for neglected global diseases research at UBC exceeds $20 million
4. Cedars-Sinai Heart Institute awarded $1.3 million to study cardiac stem cells
5. Millions of Americans Have Uncontrolled High Blood Pressure: CDC
6. Weill Cornell awarded $1.8 million for translational blood cancer research
7. UTMB receives $1.2 million to provide HPV vaccine
8. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
9. Germany launches a €16 million epigenome program
10. Fit Brains, online portfolio of cognitive games, reaches milestone of 75 million brain scores
11. NIH awards $7.8 million for innovative HIV vaccine approaches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne ... signature product of her research center at Bio-Logic Aqua Research® Water Life Science®, ... the greatest number of sufferers of blindness. “We think that Nature’s Tears® EyeMist® ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, has expanded ... healthcare services providers. , According to Peter Ohrenberger, sales director at Nastel, ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a ... for everyone affected by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon ... off on July 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using CDRH’s Medical Device ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          , Device makers ... It’s known as the “CY2016 Annual FDA Medical Device Quality System Data” report. ...
Breaking Medicine News(10 mins):
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of oral ... from the Israel Securities Authority to dual-list its common stock ... will commence trading on the TASE on July 12, 2017 ... of the Company, it is expected that Oramed will be ...
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
Breaking Medicine Technology: